Erlotinib and anorexia 
Erlotinib and anorexia Patient Reports February 11, 2012
Erlotinib Side Effects Report #5372695-X
Erlotinib side effect was reported by a Physician from JAPAN on June 05, 2007. Male patient, 77 years of age, was diagnosed with pancreatic carcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: abdominal pain lower, anorexia, cardiomegaly, cholangitis, diarrhoea, emphysema, faecaloma, hypoglycaemia, interstitial lung disease. Erlotinib dosage: 100 MG (QD), ORAL. During the same period patient was treated with GEMCITABINE, DEXAMETHASONE PHOSPHATE, OXYCODONE, SULINDAC, TEPRENONE, RABEPRAZOLE, FUROSEMIDE, AMLODIPINE BESYLATE. Patient recovered.
Erlotinib Side Effects Report #5404736-5
Erlotinib side effect was reported by a Physician from JAPAN on July 17, 2007. Male patient, 77 years of age, was diagnosed with pancreatic carcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: abdominal pain lower, anorexia, blood glucose increased, cardiomegaly, cholangitis, diarrhoea, emphysema, faecaloma, hypoglycaemia. Erlotinib dosage: 100 MG (QD), ORAL. During the same period patient was treated with GEMCITABINE, DEXAMETHASONE PHOSPHATE, OXYCODONE, SULINDAC, TEPRENONE, RABEPRAZOLE, FUROSEMIDE, AMLODIPINE BESYLATE. Patient recovered.
Erlotinib Side Effects Report #5531268-6
Erlotinib side effect was reported by a Physician from JAPAN on Nov 12, 2007. Male patient, 77 years of age, was diagnosed with pancreatic carcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: anorexia, aphasia
, cholangitis, diarrhoea, emphysema, faecaloma, granuloma, hypoglycaemia, interstitial lung disease. Erlotinib dosage: 100 MG (QD), ORAL. During the same period patient was treated with GEMCITABINE, DEXAMETHASONE PHOSPHATE, OXYCODONE, SULINDAC, TEPRENONE, RABEPRAZOLE, FUROSEMIDE, AMLODIPINE BESYLATE. Patient was hospitalized. Patient recovered.Erlotinib Side Effects Report #5573226-1
Erlotinib side effect was reported by a Physician from JAPAN on Dec 05, 2007. Male patient, 77 years of age, was diagnosed with pancreatic carcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: abdominal pain lower, anorexia, blood glucose increased, body temperature increased, cardiomegaly, central nervous system neoplasm, cholangitis, constipation
, diarrhoea. Erlotinib dosage: 100 MG (100 MG, QD), ORAL. During the same period patient was treated with GEMCITABINE, DEXAMETHASONE PHOSPHATE, OXYCODONE, SULINDAC, TEPRENONE, RABEPRAZOLE, FUROSEMIDE, AMLODIPINE BESYLATE. Patient recovered.Erlotinib Side Effects Report #6112634-7
Erlotinib side effect was reported by a Health Professional from GERMANY on Feb 23, 2009. Female patient, 66 years of age, was diagnosed with pancreatic carcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: anaemia, anorexia, lymphangiosis carcinomatosa, pain
. Erlotinib dosage: (100 MG, QD), ORAL. During the same period patient was treated with GEMCITABINE, HYDROMORPHONE, PANTOPRAZOL, DIPYRONE, METOCLOPRAMIDE, NOVALGIN. Patient was hospitalized. Patient died on 11/19/2008.Erlotinib Side Effects Report #6053251-7
Erlotinib side effect was reported by a Physician from FRANCE on Jan 07, 2009. Female patient, 62 years of age, was diagnosed with pancreatic carcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: abdominal pain
, anorexia, dysphonia, escherichia sepsis, malignant neoplasm progression, nausea , vocal cord paralysis. Erlotinib dosage: unknown. During the same period patient was treated with GEMCITABINE, IMOVANE, PROPRANOLOL, DURAGESIC, ACTISKENAN, PRIMPERAN, ZOFRAN, FORTIMEL. Patient was hospitalized. Patient died.Erlotinib Side Effects Report #5691943-X
Erlotinib side effect was reported by a Physician from JAPAN on Feb 11, 2008. Female patient, 57 years of age, was diagnosed with pancreatic carcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: anorexia, gastritis, intestinal obstruction, oral intake reduced, rash
. Erlotinib dosage: 100 MG QD ORAL. During the same period patient was treated with GEMCITABINE, OXYCODOONE, MORPHINE, OMEPRAZOLE, SUCRALFATE, LOXOPROFEN, ITOPRIDE, METOCLOPRAMIDE. Patient was hospitalized. Patient recovered.Erlotinib Side Effects Report #5731478-9
Erlotinib side effect was reported by a Physician from UNITED STATES on Apr 22, 2008. Male patient was diagnosed with pancreatic carcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: anorexia, asthenia, hyperglycaemia, hyponatraemia, pyrexia, white blood cell count increased. Erlotinib dosage: (150 MG,QD),ORAL. During the same period patient was treated with EVEROLIMUS. Patient was hospitalized. Patient recovered.
Erlotinib Side Effects Report #5776006-7
Erlotinib side effect was reported by a Physician from UNITED STATES on May 29, 2008. Male patient was diagnosed with pancreatic carcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: anorexia, ascites, chills, hyperglycaemia, hyponatraemia, malignant neoplasm progression, pyrexia. Erlotinib dosage: (150 MG, QD), ORAL. During the same period patient was treated with EVEROLIMUS. Patient was hospitalized. Patient died on 05/18/2008.
Erlotinib Side Effects Report #5877487-0
Erlotinib side effect was reported by a Physician from UNITED STATES on Aug 25, 2008. Male patient, 72 years of age, was diagnosed with oesophageal carcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: activated partial thromboplastin time prolonged, anorexia, asthenia, atrial flutter, dehydration, fatigue, haematocrit decreased, haemoglobin decreased, sinus tachycardia. Erlotinib dosage: (100 MG, QD), ORAL. During the same period patient was treated with BEVACIZUMAB, PACLITAXEL, CARBOPLATIN, FLUOROURACIL, BACTRIM, ALBUTEROL, ESOMEPRAZOLE MAGNESIUM. Patient recovered.
Erlotinib Side Effects Report #5783016-2
Erlotinib side effect was reported by a Consumer or non-health professional from UNITED STATES on June 19, 2008. Male patient, weighting 138.9 lb, was diagnosed with oesophageal adenocarcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: anorexia, disease progression, dysphagia, fatigue, nausea
, odynophagia, oral intake reduced, weight decreased. Erlotinib dosage: 150 MG, QD, PO. During the same period patient was treated with BEVACIZUMAB, PROGRAF, MYFORTIC, PREVACID, LIPITOR, PREDNISONE, METOPROLOL SUCCINATE, ASPIRIN. Patient was hospitalized. Patient recovered.Erlotinib Side Effects Report #5517708-7
Erlotinib side effect was reported by a Health Professional from UNITED STATES on Oct 29, 2007. Male patient, 93 years of age, weighting 117.1 lb, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: anorexia, chest pain
, dehydration, haemoglobin decreased, weight decreased. Erlotinib dosage: 125 MG, QD, ORAL. Patient was hospitalized. Patient recovered.Erlotinib Side Effects Report #5691881-2
Erlotinib side effect was reported by a Health Professional from UNITED STATES on Apr 01, 2008. Male patient, 84 years of age, weighting 141.0 lb, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: abdominal pain upper, anaemia, anorexia, back pain
, constipation , failure to thrive, malignant neoplasm progression, rash , weight decreased. Erlotinib dosage: 150 MG DAILY 047 PO. During the same period patient was treated with BEVACIZUMAB, HYTRIN, ZOCOR, NEURONTIN, GEMFIBROZIL, NORTRIPTYLINE, GLYBURIDE AND METFORMIN. Patient was hospitalized. Patient recovered.Erlotinib Side Effects Report #5330424-X
Erlotinib side effect was reported by a Physician from FRANCE on Apr 30, 2007. Male patient, 80 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: anorexia, glossitis, ill-defined disorder. Erlotinib dosage: unknown. During the same period patient was treated with DILTIAZEM, DAFALGAN. Patient was hospitalized. Patient died on 12/11/2006.
Erlotinib Side Effects Report #5518470-4
Erlotinib side effect was reported by a Health Professional from UNITED STATES on Nov 13, 2007. Female patient, 78 years of age, weighting 184.0 lb, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: anorexia, asthenia, diarrhoea, headache
, nausea . Erlotinib dosage: 150 MG DAILY 047. During the same period patient was treated with BEVACIZUMAB. Patient was hospitalized. Patient recovered.Erlotinib Side Effects Report #5638851-8
Erlotinib side effect was reported by a Health Professional from UNITED STATES on Feb 22, 2008. Female patient, 78 years of age, weighting 184.0 lb, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: anorexia, asthenia, diarrhoea, headache
, nausea . Erlotinib dosage: 150 MG DAILY 047. During the same period patient was treated with BEVACIZUMAB. Patient was hospitalized. Patient recovered.Erlotinib Side Effects Report #5719902-9
Erlotinib side effect was reported by a Health Professional from UNITED STATES on Apr 14, 2008. Male patient, 75 years of age, weighting 160.9 lb, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: abscess
, anaemia, anorexia, asthenia, blood creatinine increased, blood pressure decreased, bronchial carcinoma, cardio-respiratory arrest, dehydration. Erlotinib dosage: (150 MG,QD),ORAL; 9100 MG, QD), ORAL. During the same period patient was treated with MAGIC MOUTHWASH, SULINDAC, COMBIVENT. Patient was hospitalized. Patient died on 11/27/2007.Erlotinib Side Effects Report #5250757-5
Erlotinib side effect was reported by a Physician from GERMANY on Feb 09, 2007. Male patient, 74 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: anorexia, asthenia, chest pain
, constipation , dehydration, disease progression, fall , infection . Erlotinib dosage: 150 MG (QD), ORAL. During the same period patient was treated with OXYCODONE, MOVICOL, NEXIUM, NOVALGIN, INSULIN, METOCLOPRAMID, SPIRONOLACTONE. Patient was hospitalized. Patient died.Erlotinib Side Effects Report #5314281-3
Erlotinib side effect was reported by a Physician from UNITED STATES on Apr 10, 2007. Male patient, 74 years of age, weighting 132.9 lb, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: abdominal pain
, anorexia, pancreatitis acute. Erlotinib dosage: 150 MG (QD), ORAL. Patient was hospitalized. Patient recovered.Erlotinib Side Effects Report #5634112-1
Erlotinib side effect was reported by a Physician from GERMANY on Feb 14, 2008. Male patient, 74 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: anorexia, asthenia, chest pain
, constipation , dehydration, disease progression, fall , infection , nausea . Erlotinib dosage: 150 MG (150 MG, QD), ORAL. During the same period patient was treated with OXYCODONE, MOVICOL, NEXIUM, NOVALGIN, INSULIN, METOCLOPRAMID, SPIRONOLACTONE. Patient was hospitalized. Patient died.Erlotinib Side Effects Report #4644848-7
Erlotinib side effect was reported by a Physician from on Apr 08, 2005. Female patient, 71 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: anorexia, dehydration, dizziness
, syncope. Erlotinib dosage: 150 MG (QD), ORAL. Patient was hospitalized. Patient recovered.Erlotinib Side Effects Report #4700720-5
Erlotinib side effect was reported by a Physician from on June 10, 2005. Female patient, 71 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: abscess
, anorexia, dehydration, dyspnoea, neoplasm progression, respiratory failure, syncope, tumour necrosis. Erlotinib dosage: 150 MG (QD),ORAL. During the same period patient was treated with PREDNISONE, THEOPHYLLINE, HYDROCHLOROTHIAZIDE, ACETYLCYSTEINE, SPIRULINA, FLUTICASONE PROPIONATE, FORMOTEROL. Patient was hospitalized. Patient died on 05/27/2005.Erlotinib Side Effects Report #5688185-0
Erlotinib side effect was reported by a Physician from ITALY on Mar 14, 2008. Female patient, 69 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: anorexia, asthenia, delirium. Erlotinib dosage: (150 MG,QD), ORAL. Patient was hospitalized. Patient recovered.
Erlotinib Side Effects Report #5732114-8
Erlotinib side effect was reported by a Health Professional from ITALY on Apr 21, 2008. Female patient, 69 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: anorexia, asthenia, delirium, myocardial infarction. Erlotinib dosage: (150 MG, QD), ORAL. During the same period patient was treated with MORPHINE. Patient was hospitalized. Patient recovered.
Erlotinib Side Effects Report #6060234-X
Erlotinib side effect was reported by a Health Professional from BELGIUM on Jan 16, 2009. Female patient, 67 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: anorexia, diarrhoea, dizziness
, nausea , oral fungal infection, renal failure acute, weight decreased. Erlotinib dosage: 150 MG, QD, ORAL. During the same period patient was treated with REPAGLINIDE, NEBIVOLOL, TIOTROPIUM, ENOXAPARIN, SERETIDE, ALLOPURINOL, SIMVASTATIN. Patient was hospitalized. Patient recovered.Erlotinib Side Effects Report #4896286-X
Erlotinib side effect was reported by a Physician from UNITED STATES on Jan 11, 2006. Male patient, 66 years of age, weighting 151.0 lb, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: anaemia, anorexia, asthenia, bacteraemia, blood calcium decreased, blood sodium decreased, breath sounds abnormal, cardio-respiratory arrest, chest discomfort. Erlotinib dosage: 150 MG, QD, ORAL. During the same period patient was treated with AVASTIN, ASPIRIN, LOVENOX, ADVAIR DISKUS, ALBUTEROL INHALER, MS CONTIN, PERCOCET, SIMETHICONE. Patient died on 11/01/2005.
Erlotinib Side Effects Report #5924656-7
Erlotinib side effect was reported by a Health Professional from UNITED STATES on Oct 02, 2008. Male patient, 59 years of age, weighting 108.0 lb, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: anorexia, candidiasis, chronic obstructive pulmonary disease, cough, dehydration, dysphagia, electrolyte imbalance, gait disturbance, mental status changes. Erlotinib dosage: (50 MG), ORAL. During the same period patient was treated with SORAFENIB, PANTOPRAZOLE, ANESTHETIC MOUTH WASH, OXYCODONE WITH APAP, ENOXAPARIN SQ, ZOFRAN IV PM, LORAZEPAM IV PM, POTASSIUM SUPPLEMENT. Patient was hospitalized. Patient recovered.
Erlotinib Side Effects Report #5955949-5
Erlotinib side effect was reported by a Physician from UNITED STATES on Oct 27, 2008. Male patient, 59 years of age, weighting 108.0 lb, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: anorexia, asthenia, candidiasis, confusional state, cough, dehydration, dysphagia, electrolyte imbalance, mental status changes. Erlotinib dosage: (50 MG, QD), ORAL. During the same period patient was treated with SORAFENIB, PANTOPRAZOLE, ANESTHETIC MOUTH WASH, OXYCODONE WITH APAP, ENOXAPARIN SQ, ZOFRAN IV PM, LORAZEPAM IV PM. Patient was hospitalized. Patient recovered.
Erlotinib Side Effects Report #4615288-1
Erlotinib side effect was reported by a Physician from on Mar 04, 2005. Female patient, 57 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: anorexia, blood disorder, bronchopneumonia, cough, dry skin, dysphonia, headache
, insomnia, malaise. Erlotinib dosage: unknown. Patient was hospitalized. Patient recovered.Erlotinib Side Effects Report #5800628-8
Erlotinib side effect was reported by a Physician from UNITED STATES on July 02, 2008. Male patient, 47 years of age, weighting 185.2 lb, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: anorexia, dehydration. Erlotinib dosage: 150MG, ORALLY QD. During the same period patient was treated with DASATINIB. Patient was hospitalized. Patient recovered.
Erlotinib Side Effects Report #5494757-9
Erlotinib side effect was reported by a Health Professional from UNITED STATES on Oct 23, 2007. Female patient, weighting 180.0 lb, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: anorexia, asthenia, diarrhoea, headache
, nausea . Erlotinib dosage: 150 MG DAILY 047. During the same period patient was treated with BEVACIZUMAB. Patient was hospitalized. Patient recovered.Erlotinib Side Effects Report #6112610-4
Erlotinib side effect was reported by a Physician from JAPAN on Feb 23, 2009. Male patient, 80 years of age, weighting 148.8 lb, was diagnosed with lung adenocarcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: abdominal pain upper, anorexia, blood pressure abnormal, dermatitis acneiform, enterocolitis infectious, gastric mucosal lesion, gastroenteritis
, no therapeutic response, seborrhoeic dermatitis. Erlotinib dosage: (150 MG, QD), ORAL; (150 MG, QOD), ORAL. During the same period patient was treated with RABEPRAZOLE, DEPAS, PITAVASTATIN, CANDESARTAN CILEXETIL, TIZANIDINE, ZOLPIDEM, MAGNESIUM OXIDE. Patient died on 12/21/2008.Erlotinib Side Effects Report #5748796-0
Erlotinib side effect was reported by a Physician from JAPAN on May 06, 2008. Female patient, 78 years of age, was diagnosed with lung adenocarcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: anorexia, cachexia, condition aggravated, disease complication, disease progression, eating disorder
, gastroduodenal ulcer, gastrointestinal oedema. Erlotinib dosage: 150 MG, QD, ORAL. During the same period patient was treated with BETAMETHASONE, FAMOTIDINE, DEPAS. Patient died on 04/21/2008.Erlotinib Side Effects Report #6010179-6
Erlotinib side effect was reported by a Physician from JAPAN on Dec 01, 2008. Female patient, 78 years of age, was diagnosed with lung adenocarcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: anorexia, eating disorder
, gastroduodenal ulcer, gastrointestinal oedema, lung adenocarcinoma, malignant neoplasm progression, nutritional condition abnormal. Erlotinib dosage: 150 MG, QD, ORAL. During the same period patient was treated with BETAMETHASONE, FAMOTIDINE, DEPAS, RABEPRAZOLE, ALBUMIN TANNATE. Patient died on 04/21/2008.Erlotinib Side Effects Report #6051221-6
Erlotinib side effect was reported by a Physician from JAPAN on Jan 05, 2009. Male patient, 76 years of age, weighting 118.8 lb, was diagnosed with lung adenocarcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: anorexia, blood creatinine increased, dermatitis acneiform, diarrhoea, dry skin, gait disturbance, haemoglobin decreased, lung adenocarcinoma, malignant neoplasm progression. Erlotinib dosage: (150 MG, QD), ORAL. During the same period patient was treated with BETAMETHASONE, BACTRAMIN, ISOSORBIDE, ALLELOCK, PURSENNID, FAMOTIDINE, ISOSORBIDE MONONITRATE, MEXITIL. Patient was hospitalized. Patient died.
Erlotinib Side Effects Report #6132576-0
Erlotinib side effect was reported by a Physician from JAPAN on Mar 10, 2009. Male patient, 76 years of age, weighting 118.8 lb, was diagnosed with lung adenocarcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: anorexia, blood creatinine increased, dermatitis acneiform, diarrhoea, dry skin, gait disturbance, haemoglobin decreased, lung adenocarcinoma, malignant neoplasm progression. Erlotinib dosage: 150 MG, QD, ORAL. During the same period patient was treated with BETAMETHASONE, BACTRAMIN, ISOSORBIDE, ALLELOCK, PURSENNID, GASTER D, ISOSORBIDE MONONITRATE, MEXITIL. Patient was hospitalized. Patient died on 11/24/2008.
Erlotinib Side Effects Report #6099808-9
Erlotinib side effect was reported by a Physician from JAPAN on Feb 13, 2009. Female patient, 75 years of age, weighting 143.3 lb, was diagnosed with lung adenocarcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: anorexia, arterial thrombosis limb, diarrhoea, disease progression, nausea
, rash . Erlotinib dosage: (150 MG, QD), ORAL; (150 MG, QD), ORAL. During the same period patient was treated with VITAMEDIN, METHYCOBAL, PRAVASTATIN, LOXONIN, SELBEX, NAUZELIN. Patient recovered.Erlotinib Side Effects Report #5832824-8
Erlotinib side effect was reported by a Health Professional from JAPAN on July 18, 2008. Female patient, 68 years of age, was diagnosed with lung adenocarcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, anorexia, aspartate aminotransferase increased, diarrhoea, disease progression, enterocolitis infectious, epilepsy
, fatigue. Erlotinib dosage: 150 MG, QD, ORAL. During the same period patient was treated with ONEALFA, PHENYTOIN, THRYADIN. Patient was hospitalized. Patient died.Erlotinib Side Effects Report #5856881-8
Erlotinib side effect was reported by a Physician from JAPAN on Aug 07, 2008. Female patient, 67 years of age, weighting 80.25 lb, was diagnosed with lung adenocarcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: anaemia, anorexia, malaise, rash
. Erlotinib dosage: 100 MG, QD, ORAL. During the same period patient was treated with ZANTAC, MUCOSTA, LOXONIN. Patient was hospitalized. Patient recovered.Erlotinib Side Effects Report #6132581-4
Erlotinib side effect was reported by a Physician from JAPAN on Mar 09, 2009. Male patient, 65 years of age, weighting 119.5 lb, was diagnosed with lung adenocarcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: anorexia, arteriovenous fistula, dermatitis acneiform, dizziness
, gastritis atrophic, lung adenocarcinoma, malignant neoplasm progression, melaena, pseudomembranous colitis. Erlotinib dosage: 150 MG, QD, ORAL. During the same period patient was treated with FAMOTIDINE, BETAMETHASONE, MUCOSTA, ZOLPIDEM, HOKUNALIN, MAXIPIME, VITAMEDIN, METOCLOPRAMIDE. Patient was hospitalized. Patient died on 01/30/2009.Erlotinib Side Effects Report #5648134-8
Erlotinib side effect was reported by a Physician from JAPAN on Feb 14, 2008. Female patient, 62 years of age, was diagnosed with lung adenocarcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: anaemia, anorexia, constipation
, dysgeusia, gastritis, hepatic function abnormal, lung disorder, pleural effusion. Erlotinib dosage: 150 MG, QD, ORAL. During the same period patient was treated with MORPHINE, PRIMPERAN, CALCIUM LACTATE, GLYCYRON, ALFAROL, SUCRALFATE, PREDNISOLONE. Patient recovered.Erlotinib Side Effects Report #5735802-2
Erlotinib side effect was reported by a Physician from JAPAN on Apr 09, 2008. Female patient, 62 years of age, was diagnosed with lung adenocarcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: anaemia, anorexia, dysgeusia, hepatic function abnormal, lung consolidation, malignant neoplasm progression, pleural effusion. Erlotinib dosage: 150 MG, QD, ORAL. During the same period patient was treated with MORPHINE, PRIMPERAN, CALCIUM LACTATE, GLYCYRON, ALFAROL, SUCRALFATE, PREDNISOLONE. Patient died.
Erlotinib Side Effects Report #5740034-8
Erlotinib side effect was reported by a Health Professional from JAPAN on Apr 29, 2008. Female patient, 60 years of age, was diagnosed with lung adenocarcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: anorexia, dysgeusia, dyspepsia, nausea
, reflux oesophagitis. Erlotinib dosage: (150 MG,QD),ORAL. During the same period patient was treated with DEPAS, DECADRON, CLONAZEPAM, MAGNESIUM OXIDE, LAXOBERON, HYALEIN, BICARBONATE IN PLASTIC CONTAINER. Patient recovered.Erlotinib Side Effects Report #5946009-8
Erlotinib side effect was reported by a Physician from JAPAN on Oct 24, 2008. Female patient, 60 years of age, was diagnosed with lung adenocarcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: anorexia, cough, diarrhoea, dry eye, dry mouth, dysgeusia, dyspepsia, metastases to central nervous system, nausea
. Erlotinib dosage: (150 MG,QD), ORAL. During the same period patient was treated with DEPAS, DECADRON, CLONAZEPAM, MAGNESIUM OXIDE, LAXOBERON, HYALEIN, BICARBONATE IN PLASTIC CONTAINER. Patient recovered.Erlotinib Side Effects Report #5988405-9
Erlotinib side effect was reported by a Health Professional from JAPAN on Nov 19, 2008. Female patient, 60 years of age, was diagnosed with lung adenocarcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: anorexia, dysgeusia, dyspepsia, nausea
, reflux oesophagitis. Erlotinib dosage: (150 MG, QD), ORAL. During the same period patient was treated with DEPAS, DECADRON, CLONAZEPAM, MAGNESIUM OXIDE, LAXOBERON, HYALEIN, BICARBONATE IN PLASTIC CONTAINER. Patient recovered.Erlotinib Side Effects Report #6022315-6
Erlotinib side effect was reported by a Physician from JAPAN on Dec 11, 2008. Male patient, 60 years of age, was diagnosed with lung adenocarcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: anorexia, blood creatinine increased, blood urea increased, dermatitis acneiform, diarrhoea, disease progression, dry skin, fatigue, hypochloraemia. Erlotinib dosage: (150 MG, QD) ,ORAL. During the same period patient was treated with OXYCONTIN, MORPHINE, RINDERON, BACTRAMIN, LOXONIN, MUCOSTA. Patient was hospitalized. Patient died.
Erlotinib Side Effects Report #6073104-8
Erlotinib side effect was reported by a Physician from JAPAN on Jan 22, 2009. Female patient, 60 years of age, was diagnosed with lung adenocarcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, anorexia, arrhythmia
, aspartate aminotransferase increased, atrial fibrillation , cough, diarrhoea, dry eye, dysgeusia. Erlotinib dosage: (150 MG,QD),ORAL ; (50 MG),ORAL. During the same period patient was treated with DEPAS, DECADRON, CLONAZEPAM, MAGNESIUM OXIDE, LAXOBERON, HYALEIN, BICARBONATE IN PLASTIC CONTAINER, MORPHINE. Patient died on 12/31/2008.Erlotinib Side Effects Report #5836130-7
Erlotinib side effect was reported by a Physician from JAPAN on July 22, 2008. Male patient, 52 years of age, was diagnosed with lung adenocarcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: anorexia, atrial septal defect, cardiovascular disorder, convulsion, dermatitis acneiform, diarrhoea, lung neoplasm malignant, malignant neoplasm progression, metastases to central nervous system. Erlotinib dosage: 150 MG, QD, ORAL. During the same period patient was treated with URSO, HOCHU, MOHRUS. Patient was hospitalized. Patient recovered.
Erlotinib Side Effects Report #5324242-6
Erlotinib side effect was reported by a Health Professional from UNITED STATES on Apr 23, 2007. Male patient, 54 years of age, was diagnosed with hepatic neoplasm malignant and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: activities of daily living impaired, anorexia, disease progression, failure to thrive, hallucination, hepatomegaly, metastases to liver, performance status decreased. Erlotinib dosage: 150 MG (QD), ORAL. During the same period patient was treated with BEVACIZUMAB, MARINOL, ATENOLOL, NEXIUM, SENOKOT, FENTANYL PATCH, ACTIQ. Patient was hospitalized. Patient died on 03/16/2007.
Erlotinib Side Effects Report #5607503-2
Erlotinib side effect was reported by a Health Professional from UNITED STATES on Jan 10, 2008. Male patient, 70 years of age, was diagnosed with colorectal cancer
and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: anorexia, blood urea increased, condition aggravated, dehydration, fatigue, fistula , haematocrit decreased, hyperglycaemia, platelet count decreased. Erlotinib dosage: 75 MG (QD), ORAL. During the same period patient was treated with BEVACIZUMAB, EVEROLIMUS, NITROFURANTOIN, OXYCODONE, OXYCONTIN, CENTRUM, ENABLEX, DITROPAN. Patient was hospitalized. Patient recovered.Erlotinib Side Effects Report #5446954-6
Erlotinib side effect was reported by a Health Professional from UNITED STATES on Aug 31, 2007. Male patient was diagnosed with colorectal cancer
and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: anorexia, dehydration, fatigue, fistula , hyperglycaemia, stress . Erlotinib dosage: 75 MG, QD. During the same period patient was treated with BEVACIZUMAB, EVEROLIMUS, DITROPAN, PRILOSEC, NORVASC. Patient was hospitalized. Patient recovered.Erlotinib Side Effects Report #5529685-3
Erlotinib side effect was reported by a Health Professional from UNITED STATES on Nov 12, 2007. Female patient, 44 years of age, was diagnosed with colon cancer metastatic, breast cancer metastatic and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: anorexia, constipation
, dehydration, haemoglobin decreased, lethargy, nausea , platelet count decreased, pneumonia . Erlotinib dosage: 75 MG, QD, ORAL. During the same period patient was treated with VINFLUNINE, FENTANYL PATCH, OXYCODONE, KYTRIL, PROMETHAZINE, LEVSIN, MORPHINE, DIAZEPAM. Patient was hospitalized. Patient recovered.Erlotinib Side Effects Report #4814847-0
Erlotinib side effect was reported by a Health Professional from UNITED STATES on Oct 27, 2005. Male patient, weighting 154.3 lb, was diagnosed with colon cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: anaemia, anorexia, asthenia, confusional state, dehydration, diarrhoea, failure to thrive, laboratory test interference, orthostatic hypotension. Erlotinib dosage: 100MG QD ORAL. During the same period patient was treated with FLUOROURACIL, OXALIPLATIN, AVASTIN. Patient was hospitalized. Patient recovered.
Erlotinib Side Effects Report #5125290-1
Erlotinib side effect was reported by a Health Professional from UNITED STATES on Sept 22, 2006. Male patient, 67 years of age, weighting 163.8 lb, was diagnosed with carcinoid tumour and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: abdominal pain
, anaemia, anorexia, asthenia, chest pain , confusional state, dehydration, diarrhoea, fatigue. Erlotinib dosage: unknown. During the same period patient was treated with GLYBURIDE, FERROUS SULPHATE, KEPPRA, LORTAB, SANDOSTATIN, ZOMETA. Patient was hospitalized. Patient recovered.Erlotinib Side Effects Report #5235112-6
Erlotinib side effect was reported by a Physician from FRANCE on Jan 22, 2007. Male patient, 80 years of age, was treated with Erlotinib. After drug was administered, patient experienced the following side effects: anorexia, glossitis. Erlotinib dosage: unknown. During the same period patient was treated with DILTIAZEM, DAFALGAN. Patient was hospitalized. Patient recovered.
Erlotinib Side Effects Report #6051310-6
Erlotinib side effect was reported by a Physician from JAPAN on Jan 05, 2009. Male patient, 77 years of age, weighting 90.39 lb, was treated with Erlotinib. After drug was administered, patient experienced the following side effects: anorexia, constipation
, diarrhoea, dyspnoea, exfoliative rash, fatigue, toothache, vomiting. Erlotinib dosage: (150 MG, QD), ORAL. During the same period patient was treated with SUNRYTHM, MUCOSTA, MUCOSOLVAN, SPIRIVA, TIZANIDINE, URSO, NEO MINOPHAGEN C, VERAPAMIL HYDROCHLORIDE. Patient was hospitalized. Patient recovered.Erlotinib Side Effects Report #6132578-4
Erlotinib side effect was reported by a Physician from JAPAN on Mar 10, 2009. Male patient, 77 years of age, weighting 90.39 lb, was treated with Erlotinib. After drug was administered, patient experienced the following side effects: anorexia, atelectasis, constipation
, diarrhoea, emphysema, hypersensitivity, skin exfoliation. Erlotinib dosage: 150 MG, QD, ORAL. During the same period patient was treated with SUNRYTHM, MUCOSTA, MUCOSOLVAN, SPIRIVA, TIZANIDINE, URSO, NEO MINOPHAGEN C, VERAPAMIL HYDROCHLORIDE. Patient was hospitalized. Patient recovered.Erlotinib Side Effects Report #5643837-3
Erlotinib side effect was reported by a Health Professional from UNITED STATES on Feb 11, 2008. Male patient, 75 years of age, weighting 160.9 lb, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: abscess
, anaemia, anorexia, asthenia, blood creatinine increased, dehydration, dermal cyst, failure to thrive, gastrointestinal haemorrhage. Erlotinib dosage: 150 MG, QD, ORAL, 100 MG, QD, ORAL. During the same period patient was treated with MAGIC MOUTHWASH, SULINDAC, COMBIVENT. Patient was hospitalized. Patient died on 11/27/2007.Erlotinib Side Effects Report #5677827-1
Erlotinib side effect was reported by a Health Professional from UNITED STATES on Mar 04, 2008. Male patient, 75 years of age, weighting 160.9 lb, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: abscess
, anaemia, anorexia, asthenia, blood creatine increased, blood urea increased, cardio-respiratory arrest, dehydration, dermal cyst. Erlotinib dosage: 150 MG, QD, ORAL; 100 MG, QD, ORAL. During the same period patient was treated with MAGIC MOUTHWASH, SULINDAC, COMBIVENT. Patient was hospitalized. Patient died on 11/27/2007.Erlotinib Side Effects Report #5284210-X
Erlotinib side effect was reported by a Health Professional from UNITED STATES on Mar 30, 2007. Female patient, 72 years of age, weighting 151.5 lb, was diagnosed with salivary gland cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: anorexia, blood sodium decreased, eye infection
, fatigue, nausea , oral discomfort, staphylococcal infection . Erlotinib dosage: 75 MG PO QD. During the same period patient was treated with VINFLUNINE. Patient was hospitalized. Patient recovered.Erlotinib Side Effects Report #5088393-6
Erlotinib side effect was reported by a Health Professional from UNITED STATES on July 10, 2006. Male patient, 66 years of age, was treated with Erlotinib. After drug was administered, patient experienced the following side effects: anorexia, dehydration, diarrhoea, hypercalcaemia, nausea
, urinary tract infection , weight decreased. Erlotinib dosage: 150 MG (QD),ORAL. During the same period patient was treated with CETUXIMAB, ASPIRIN, NAPROXEN, LEVAQUIN. Patient was hospitalized. Patient recovered.